To the Editor The article by Guo et al1 presents initial findings for the SEIPLUS study, a randomized clinical trial exploring the value of extensive intraoperative peritoneal lavage (EIPL) for treatment of locally advanced gastric cancer. As highlighted by Levine2 in an accompanying Invited Commentary, the accrual for this trial occurred during a remarkably short period, and EIPL appears to be a simple, safe, and low-cost method to decrease the peritoneal metastases rates.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Batista TP. Combination of Surgery With Extensive Intraoperative Peritoneal Lavage for Patients With Advanced Gastric Cancer. JAMA Surg. 2019;154(12):1162–1163. doi:10.1001/jamasurg.2019.2655
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.